CI Investments Inc
TXG icon

CI Investments Inc’s 10x Genomics TXG Stock Holding History

CI Investments Inc’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,695
Closed -$67K – 1344
2025
Q1 		$67K Sell
7,695
-35
-0.5% -$441 ﹤0.01% 1002
2024
Q4 		$111K Buy
7,730
+2,897
+60% +$45.7K ﹤0.01% 913
2024
Q3 		$109K Sell
4,833
-145
-3% -$3K ﹤0.01% 834
2024
Q2 		$97K Buy
4,978
+2,517
+102% +$65.9K ﹤0.01% 826
2024
Q1 		$92K Buy
2,461
+46
+2% +$2.02K ﹤0.01% 915
2023
Q4 		$135K Buy
2,415
+606
+33% +$26.4K ﹤0.01% 770
2023
Q3 		$75K Sell
1,809
-44
-2% -$2.29K ﹤0.01% 884
2023
Q2 		$103K Sell
1,853
-866
-32% -$46.9K ﹤0.01% 783
2023
Q1 		$152K Sell
2,719
-35
-1% -$1.63K ﹤0.01% 647
2022
Q4 		$100K Buy
2,754
+2,409
+698% +$78.8K ﹤0.01% 749
2022
Q3 		$10K Sell
345
-152
-31% -$5.79K ﹤0.01% 1133
2022
Q2 		$22K Sell
497
-98
-16% -$5.08K ﹤0.01% 962
2022
Q1 		$45K Buy
595
+151
+34% +$13.2K ﹤0.01% 970
2021
Q4 		$66K Buy
444
+96
+28% +$14.7K ﹤0.01% 971
2021
Q3 		$51K Buy
+348
New +$59.7K ﹤0.01% 967

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CI Investments Inc's TXG Position: Q2 2025 in Review

CI Investments Inc sold out of 10x Genomics (TXG) in Q2 2025, closing a stake of 7,695 shares — an estimated $67K sold.

CI Investments Inc first reported a position in TXG in Q3 2021 and held it in 15 quarters. The position peaked at $152K in Q1 2023. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

  • CI Investments Inc reported no remaining 10x Genomics position as of Q2 2025 after selling out during the quarter.
  • CI Investments Inc sold 7,695 10x Genomics shares in Q2 2025, an estimated $67K.
  • CI Investments Inc first reported a position in 10x Genomics in Q3 2021 and held it in 15 quarters.
  • CI Investments Inc's 10x Genomics position peaked at $152K in Q1 2023.
  • 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on CI Investments Inc's 13F filing for Q2 2025, filed 12 Aug 2025.